Transit Scientific Reports the US FDA Approval of Next-Generation Microcatheter
Shots:
- Transit Scientific receives the US FDA approval for its microcatheter designed to precisely deliver embolic agents, signifying a significant leap in microcatheter technology & providing clinicians with an innovative tool to enhance patient care.
- The 510k clearance involves the XO Cath 2F Microcatheter with 0.021" ID & the XO Cath 2.6F Microcatheter with 0.027" ID. These are compatible with standard 0.014", 0.018", & 0.021" guidewires
- XO Cath microcatheter surpasses current limitations, offering superior trackability, torque response, and embolic compatibility. Its non-tapered metal-alloy construction ensures precise control over embolic material placement for enhanced minimally invasive procedures
Ref: PR Newswire | Image: Transit Scientific
Related News:- Johnson & Johnson (J&J) Vision Launches Acuvue Oasys with Transitions Light Intelligent Technology in the US
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Kritika is a content writer at PharmaShots. She is interested in covering recent innovations from the pharma & MedTech industry. She covers news related to Product approvals, clinical trial results, and updates. She can be contacted at connect@pharmashots.com.
